share_log

19th Annual Double Helix Medals Dinner Raises $7 Million

19th Annual Double Helix Medals Dinner Raises $7 Million

第19屆雙螺旋獎晚宴籌集了700萬美元
PR Newswire ·  05:16

NEW YORK, Nov. 15, 2024 /PRNewswire/ -- On November 14, Cold Spring Harbor Laboratory (CSHL) held its 19th annual Double Helix Medals dinner (DHMD) at the American Museum of Natural History in New York City. The event, emceed by CBS journalist Lesley Stahl, honored Alisa and Daniel Doctoroff and 2023 Nobel laureate Dr. Katalin Karikó. With the support of the event chairs and donors, the gala raised $7 million for biology research and education at CSHL.

紐約,2024年11月15日 /PRNewswire/ -- 11月14日,冷春港實驗室(CSHL)在紐約市的美國自然歷史博物館舉行了第19屆雙螺旋獎牌晚宴(DHMD)。該活動由CBS記者Lesley Stahl主持,表彰了Alisa和Daniel Doctoroff以及2023年諾貝爾獎獲得者Katalin Karikó博士。在活動主席和捐助者的支持下,晚會爲CSHL的生物學研究和教育籌集了700萬美元。

Left to right: CSHL President and CEO Bruce Stillman, CSHL Board of Trustees Chair Marilyn Simons, and 2022 Double Helix Medal recipients Albert Bourla and Jennifer A. Doudna. Bourla and Doudna were honored for their contributions to genetics research and public health. Image: Sean Zanni / Patrick McMullan Company
從左至右:CSHL總裁兼首席執行官Bruce Stillman,CSHL董事會主席Marilyn Simons,以及2022年雙螺旋獎獲得者Albert Bourla與Jennifer A. Doudna。Bourla和Doudna因其對遺傳學研究和公共衛生的貢獻而受到表彰。圖片來源:Sean Zanni / Patrick McMullan Company

Alisa and Daniel Doctoroff are leaders of Target ALS, an innovative nonprofit that has sparked dramatic progress in research on amyotrophic lateral sclerosis (ALS). Before being diagnosed with this neurodegenerative disease, Mr. Doctoroff served as New York City Deputy Mayor for Economic Development and Rebuilding and as CEO and president of Bloomberg L.P. He is the founder and board chair of Target ALS.

Alisa和Daniel Doctoroff是Target ALS的領導者,這是一家創新的非營利組織,已在肌萎縮側索硬化症(ALS)的研究中取得了顯著進展。在被診斷出這種神經退行性疾病之前,Doctoroff先生曾擔任紐約市經濟發展與重建副市長,以及Bloomberg L.P.的首席執行官和總裁。他是Target ALS的創始人和董事會主席。

"My goal for Target ALS is our mission statement, 'Everyone lives.' We are in sight of that goal," says Mr. Doctoroff. "We can see the day coming, and there are smaller goals that will get us there," adds Mrs. Doctoroff. "We are, one by one, achieving and attacking those goals and getting to the point where everyone lives with ALS."

「我對Target ALS的目標就是我們的使命宣言『人人生存。』我們已經看到了這個目標的曙光,」Doctoroff先生說。「我們可以看到那一天的到來,目標有一個個地實現,」Doctoroff夫人補充道。「我們正在逐個達成並攻克這些目標,達到每個ALS患者都有生活的那一刻。」

Dr. Katalin Karikó is a winner of the 2023 Nobel Prize in Physiology or Medicine and a professor at the University of Szeged in Hungary. Her revolutionary biomedical advancements at the University of Pennsylvania and later at the pharmaceutical company BioNTech created the blueprint for mRNA vaccines, saving millions of lives. Despite this success, she remains humble as ever.

Katalin Karikó博士是2023年諾貝爾生理學或醫學獎的獲得者,現爲匈牙利塞格德大學的教授。她在賓夕法尼亞大學以及後來的biontech製藥公司取得的革命性生物醫藥進展,爲mRNA疫苗創建了藍圖,挽救了數百萬的生命。儘管取得了這樣的成功,她依然保持謙遜。

"Getting a Nobel Prize, I realized that attention is on the science and the scientist," Dr. Karikó says. "I receive a lot of awards, but every time, I emphasize that a lot of scientists contributed. I want to be remembered as an honest, cheerful, happy scientist. That's it."

「獲得諾貝爾獎後,我意識到注意力集中在科學和科學家身上,」Karikó博士說。「我獲得了很多獎項,但每次我都強調有很多科學家參與了這項工作。我希望被記住的是一個誠實、樂觀、快樂的科學家。就這樣。」

The 2024 DHMD was chaired by Dr. Neri Oxman and Mr. William Ackman, Ms. Jamie Nicholls and Mr. O. Francis Biondi, Mr. and Mrs. David Boies, Dr. Albert Bourla and Pfizer, Inc., Ms. Barbara Amonson and Dr. Vincent Della Pietra, Drs. Pamela Hurst-Della Pietra and Stephen Della Pietra, Mr. and Mrs. John Desmarais, Mr. and Mrs. Jeffrey E. Kelter, Dr. and Mrs. Tomislav Kundic, Mr. and Mrs. Robert D. Lindsay, Ms. Ivana Stolnik-Lourie and Dr. Robert Lourie, Dr. Marcia Kramer Mayer, Dr. and Mrs. Howard L. Morgan, Mr. and Mrs. Tom Secunda, Dr. Marilyn H. Simons, and Mr. and Mrs. Paul J. Taubman.

2024年DHMD由Neri Oxman博士和William Ackman先生主持,還有Jamie Nicholls女士和O. Francis Biondi先生、David Boies夫婦、Albert Bourla博士和輝瑞公司、Barbara Amonson女士和Vincent Della Pietra博士、Pamela Hurst-Della Pietra博士和Stephen Della Pietra博士、John Desmarais夫婦、Jeffrey E. Kelter夫婦、Tomislav Kundic博士和夫人、Robert D. Lindsay夫婦、Ivana Stolnik-Lourie女士和Robert Lourie博士、Marcia Kramer Mayer博士、Howard L. Morgan博士和夫人、Tom Secunda夫婦、Marilyn H. Simons博士以及Paul J. Taubman夫婦。

Since 2006, the DHMD has raised over $67 million to support CSHL's research and education programs.

自2006年以來,DHMD已經籌集超過6700萬美元,以支持CSHL的研究和教育項目。

About Cold Spring Harbor Laboratory
Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory employs 1,000 people including 600 scientists, students and technicians. For more information, visit

關於Cold Spring Harbor Laboratory
成立於1890年,Cold Spring Harbor Laboratory 在癌症、神經科學、植物生物學和數量生物學領域塑造了當代生物醫藥研究和教育,擁有八位諾貝爾獎獲得者,這傢俬立、非營利實驗室共有1000名員工,包括600名科學家、學生和技術人員。欲了解更多信息,請訪問

SOURCE Cold Spring Harbor Laboratory

來源:Cold Spring Harbor Laboratory

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?

440k+
440k+

Newsrooms &
新聞發佈室&

Influencers
影響力人士
9k+
9k+

Digital Media
數字媒體

Outlets
Outlets
270k+
270k+

Journalists
記者

Opted In
Opted In
GET STARTED
開始使用

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論